Search all trials

Find therapies in clinical trials near you – page 3

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Hepatic fibrosis+2

Recruiting

Investigational

Study on Efruxifermin for Patients with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Efruxifermin

Contact Research Centre

Hepatic cirrhosis+2

Recruiting

Investigational

Study on Efruxifermin for Patients with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Efruxifermin

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drugNo placebo

Adjuvant Therapy with RO7435846 (divarasib) versus Pembrolizumab or Nivolumab or Observation in Patients After Surgery for Stage II‑III KRAS G12C NSCLC

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Divarasib

Contact Research Centre

Idiopathic pulmonary fibrosis

Recruiting

Investigational

Efficacy and Safety of Oral PIPE-791 in Adults with Idiopathic Pulmonary Fibrosis: A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study

Investigational

Italy

Participants:18–64 years · 65+ years

Contact Research Centre

Idiopathic pulmonary fibrosis

Recruiting

Investigational

Phase IIb Study of AZD8965 versus Placebo in Adults with Idiopathic Pulmonary Fibrosis

Investigational

Italy

Participants:18–64 years · 65+ years

Contact Research Centre

Systemic scleroderma

Recruiting

Investigational

A double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Bi 1015550

Contact Research Centre

Type 2 diabetes mellitus

Recruiting

Registered drugNo placebo

A Phase III Study of Elecoglipron Compared with Semaglutide for Adults with Type 2 Diabetes Mellitus

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Azd5004

Contact Research Centre

Cholangitis sclerosing

Recruiting

Investigational

A Phase III Study of Elafibranor in Adults with Primary Sclerosing Cholangitis to Assess Efficacy and Safety

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Elafibranor

Contact Research Centre

HIV infection

Recruiting

Registered drugNo placebo

Switching to Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults with HIV-1: A Phase 3 Randomized Study

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Abacavir

Contact Research Centre

Systemic lupus erythematosus+3

Recruiting

Investigational

A Phase 3 Study of Enpatoran to Treat Active Cutaneous Lupus in Patients With or Without Systemic Disease

Investigational

Italy

Participants:18–64 years · 65+ years

Contact Research Centre

Bladder cancer

Recruiting

Registered drugNo placebo

Study of Enfortumab Vedotin and Pembrolizumab for Bladder Preservation in Patients with Muscle‑Invasive Bladder Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Enfortumab Vedotin

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drug

Study of MK-1084 plus durvalumab versus placebo plus durvalumab in patients with locally advanced KRAS G12C‑mutant non‑small cell lung cancer after chemoradiotherapy

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Find therapies in clinical trials near you – page 3

381 trials match your criteria

Hepatic fibrosis+2

Study on Efruxifermin for Patients with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis

Hepatic cirrhosis+2

Study on Efruxifermin for Patients with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Non-small cell lung cancer

Adjuvant Therapy with RO7435846 (divarasib) versus Pembrolizumab or Nivolumab or Observation in Patients After Surgery for Stage II‑III KRAS G12C NSCLC

Idiopathic pulmonary fibrosis

Efficacy and Safety of Oral PIPE-791 in Adults with Idiopathic Pulmonary Fibrosis: A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study

Idiopathic pulmonary fibrosis

Phase IIb Study of AZD8965 versus Placebo in Adults with Idiopathic Pulmonary Fibrosis

Systemic scleroderma

A double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis

Type 2 diabetes mellitus

A Phase III Study of Elecoglipron Compared with Semaglutide for Adults with Type 2 Diabetes Mellitus

Cholangitis sclerosing

A Phase III Study of Elafibranor in Adults with Primary Sclerosing Cholangitis to Assess Efficacy and Safety

HIV infection

Switching to Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults with HIV-1: A Phase 3 Randomized Study

Systemic lupus erythematosus+3

A Phase 3 Study of Enpatoran to Treat Active Cutaneous Lupus in Patients With or Without Systemic Disease

Bladder cancer

Study of Enfortumab Vedotin and Pembrolizumab for Bladder Preservation in Patients with Muscle‑Invasive Bladder Cancer

Non-small cell lung cancer

Study of MK-1084 plus durvalumab versus placebo plus durvalumab in patients with locally advanced KRAS G12C‑mutant non‑small cell lung cancer after chemoradiotherapy

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.